According to MobiHealthNews, AI giants OpenAI and Anthropic have taken formal steps toward potential initial public offerings (IPOs). Anthropic confidentially submitted a draft Form S-1 registration statement to the U.S. Securities and Exchange Commission (SEC) about a week ago, intending to issue common shares. Meanwhile, OpenAI CEO Sam Altman told employees that the company expects to go public in the next year, with a target valuation of up to $1 trillion. Both companies are continuously expanding their AI tools into healthcare, including clinical workflows, life sciences, and hospital systems.
In the healthcare sector, these potential IPOs could provide clearer insight into how OpenAI and Anthropic monetize AI tools within regulated markets such as hospitals, health systems, payers, clinicians, and pharmaceutical companies. Earlier, health-tracking ring maker Oura also filed a confidential IPO registration with the SEC in May of this year. As AI adoption deepens in medical fields, capital markets will pay greater attention to these companies’ business models and compliance capabilities.
